The raised guidance and strong Same-Store NOI growth across SHOP and ISHC segments signal continued operational momentum. Watch for execution on the >$1.0B investment pipeline expected to close by Q1 2027 and the pace of ATM share issuance given ~$1.32B in unsettled forward sale agreements.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 6 $57.91entry
- T+1 · 8d ago +1.81%α −0.55% · $58.96
- T+5 · 4d ago −0.22%α −2.82% · $57.78
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
American Healthcare REIT reported Q3 2026 NFFO of $0.58 per diluted share, above the $0.56 consensus, and raised full-year 2026 NFFO guidance to $2.23-$2.26 per share (from $2.15-$2.19). Total portfolio Same-Store NOI grew 13.8% YoY, led by SHOP (+28.2%) and ISHC (+15.7%). The company acquired $1.69B of SHOP assets in Q3 and completed a $819M follow-on equity offering, ending the quarter with Net Debt-to-Annualized Adjusted EBITDA of 1.9x.
Key Financial Metrics
Key Facts
- Q3 2026 NFFO per diluted share of $0.58 vs consensus $0.56 (beat)
- Full-year 2026 NFFO guidance raised to $2.23-$2.26 per share from $2.15-$2.19
- Total portfolio Same-Store NOI growth of 13.8% YoY in Q3
- SHOP Same-Store NOI growth of 28.2% YoY; ISHC Same-Store NOI growth of 15.7%
- Acquired 17 SHOP assets for ~$1.69B in Q3; YTD 2026 investments total ~$2.07B
- Completed August 2026 follow-on equity offering for ~$819M in gross proceeds
- Net Debt-to-Annualized Adjusted EBITDA improved to 1.9x from 2.5x at June 30, 2026
- Total liquidity of ~$2.35B as of September 30, 2026
- Q3 2026 GAAP net income attributable to controlling interest of $31.2M, or $0.14 per diluted share
- Quarterly cash distribution of $0.25 per share declared and paid
Financial Impact
Q3 NFFO $0.58 vs $0.56 consensus; FY 2026 NFFO guidance raised to $2.23-$2.26 midpoint $2.245 vs prior $2.15-$2.19 midpoint $2.17; Same-Store NOI growth guidance raised to 12.0%-14.0% from 11.0%-13.0%
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| ISHC | $345.5M | +4.8% |
| SHOP | $74.9M | +9.0% |
| Outpatient Medical | $28.5M | +2.7% |
| Triple-Net Leased Properties | $8.0M | +1.4% |
Risk Factors
- Significant share dilution from ATM and follow-on offerings (231.5M shares outstanding at Sep 30, 2026 vs 185.9M at Dec 31, 2025)
- Execution risk on deploying the >$1.0B investment pipeline and integrating 17 new SHOP assets
- Interest rate exposure on $550M term loan maturing in 2027 with floating-rate swaps expiring January 2027
- Dependence on operator partners (Trilogy Management Services operates 100% of ISHC segment)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-449893 |
| Document: ahr-ex99_1.htm | 0001193125-26-449893 |
| Document: ahr-20261105.htm | 0001193125-26-449893 |
| Document: 0001193125-26-449893-index-headers.html | 0001193125-26-449893 |
| Document: 0001193125-26-449893-index.html | 0001193125-26-449893 |
| Document: 0001193125-26-449893.txt | 0001193125-26-449893 |
| 8-K Data (Synthetic) | 0001193125-26-449893 |
Track record
17 reports on AHR
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +16.64% at T+60 after the Jun 11, 2026 report. 5 of 6 went positive at some point.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $59.23 Now $58.07 −1.96% settles Dec 10
- Nov 6, 202610d ago 8-K Bearish 5/10 Entry $58.96 Now $58.07 +1.51% settles Dec 8
- Nov 6, 202610d ago 424B5 Bearish 5/10 Entry $58.96 Now $58.07 +1.51% settles Dec 8
- Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $57.91 Now $58.07 +0.28% settles Dec 7
- Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $52.94 Now $58.07 +9.69% settles Nov 27
- Sep 18, 20268w ago 8-K Neutral 2/10 Entry $52.05 to $52.45 Now $58.07 +11.57% ▲ +0.77% +1.68% vs SPY
- Sep 14, 20269w ago 8-K Neutral 2/10 Entry $53.40 to $52.52 Now $58.07 +8.75% ▼ −1.65% −3.91% vs SPY
- Aug 24, 202612w ago 8-K Neutral 4/10 Entry $57.05 to $51.70 Now $58.07 +1.79% ▼ −9.38% −10.35% vs SPY
- Aug 10, 202614w ago 424B5 Mixed 6/10 Entry $52.69 to $53.77 Now $58.07 +10.21% ▲ +2.05% +3.11% vs SPY
- Aug 10, 202614w ago 8-K Mixed 6/10 Entry $52.69 to $53.77 Now $58.07 +10.21% ▲ +2.05% +3.11% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers